Description:

The relatively new and growing application of genetic testing and gene therapy within the realm of eye care has brought to the forefront numerous ethical and legal considerations.  In this course we will discuss ethical considerations relating to genetic testing, primarily data privacy and confidentiality. We will also look at several clinical scenarios that bring up ethical questions. We will speculate on future ethical dilemmas, as researchers are currently using CRISPR technology to develop new gene editing techniques.  Unfortunately, not all these ethical questions have clear answers. To help guide decision making, current recommendations by the American Academy of Ophthalmology's Task Force on Genetic Testing and the American Medical Association will be examined.  Lastly, we will cover current laws that regulate genetic discrimination in the United States.

Course Code:

AOA103-EJ

Speaker(s):

Rachelle Lin, O.D.
rachelle.lin@gmail.com

Credits:

1

AOA Expiration Date:

3/30/2024

Related News

AOA sees positives in federal children’s eye health legislation

The federal effort to promote early detection of pediatric vision impairments comes as the AOA works toward a multi-year, national eye health and vision mobilization for children.

Study underestimates doctors of optometry providing eye care to children

Doctors of optometry say they are underrepresented in a recent study, even though they provide the vast majority of eye care in the U.S.

The heat is on: Ensure patients’ protective eyewear is, too

Some doctors of optometry may see an increase in patients seeking care during the summer months, whether they’re playing sports or battling dry air conditions. Be prepared to share your expertise.